Trial intelligence / Profile preview

Low Dose Tranexamic Acid in Middle Ear Surgery

NCT06434636Completed

Sponsor
Erciyes University
Start
Dec 2024
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in otitis media (2 arms), sponsored by Erciyes University. Primary endpoints: Boezaart et al grading scale and Surgeon Satisfaction Score. Started Dec 2024; status: completed.

02

Drugs

tranexamic acid
03

Conditions

otitis media

Beyond the preview

Go deeper on NCT06434636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06434636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call